“Short-term oral administration of risperidone induces pancreatic damage and hyperamylasemia in Sprague-dawley rats”, Braz. J. Pharm. Sci., vol. 54, no. 4, p. e17841, Dec. 2018, doi: 10.1590/s2175-97902018000417841.